BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
See today's BioWorld Asia
Home
» Regulatory actions for Feb. 3, 2026
To read the full story,
subscribe
or
sign in
.
Regulatory actions for Feb. 3, 2026
Feb. 3, 2026
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations in Asia-Pacific: Almirall, Bioarctic, Biogen, Drug Farm, Eisai, Huahui, Otsuka, Quoin.
BioWorld Asia
Briefs
Regulatory actions